INIS
reduction
100%
in vivo
100%
erythrocytes
100%
oxidants
100%
thalassemia
100%
damage
71%
membranes
57%
antioxidants
57%
therapy
42%
anemias
42%
mice
28%
indicators
28%
plasma
28%
doses
14%
humans
14%
administration
14%
design
14%
bilirubin
14%
transport
14%
iron
14%
lactate dehydrogenase
14%
flavonoids
14%
lipids
14%
vitamin e
14%
dehydration
14%
erythropoiesis
14%
reticulocytes
14%
Keyphrases
Erythrocytes
100%
Murine Model
100%
β-Thalassemia (β-thal)
100%
Oxidant Stress
100%
Oxidative Damage
83%
Anemia
50%
K Content
33%
Antioxidant Therapy
33%
Red Cells
16%
Mouse Model
16%
Total Bilirubin
16%
Lactate Dehydrogenase
16%
Vitamin E
16%
Membrane Binding
16%
Improved Survival
16%
Dehydration
16%
Semi-synthetic
16%
K-Cl Cotransporter
16%
Reduced Cell
16%
Thalassemia
16%
Phosphatidylserine Externalization
16%
Lipid Membrane
16%
Antioxidant Effect
16%
Synthetic Flavonoid
16%
MonoHER
16%
Flavonoids Antioxidants
16%
Membrane Peroxidation
16%
Thalassemia Intermedia
16%
Ineffective Erythropoiesis
16%
Plasma Iron
16%
Reticulocyte Count
16%
Thalassemic Mice
16%
Twice a Day
16%
Once a Day
16%
Medicine and Dentistry
Oxidative Stress
100%
Erythrocyte
100%
Beta Thalassemia
100%
Oxidizing Agent
83%
Antioxidant
66%
Anemia
50%
Lactate Dehydrogenase
16%
Flavonoid
16%
Prematurity
16%
Phosphatidylserine
16%
Alpha Tocopherol
16%
Bilirubin
16%
Membrane Lipid
16%
Thalassemia Intermedia
16%
Lipid Membrane
16%
Ineffective Erythropoiesis
16%
Serum Iron
16%
Thalassemia
16%
Reticulocyte
16%
Biochemistry, Genetics and Molecular Biology
Oxidative Stress
100%
Lactate Dehydrogenase
50%
Mouse Model
50%
Erythropoiesis
50%
Serum Iron
50%
Phosphatidylserine
50%
Peroxidation
50%
Membrane Lipid
50%
Flavonoid Antioxidants
50%
Reticulocyte Count
50%
Blood Plasma
50%
Vitamin E
50%
Bilirubin
50%
Pharmacology, Toxicology and Pharmaceutical Science
Oxidizing Agent
100%
Beta Thalassemia
100%
Antioxidant
42%
Anemia
42%
Prematurity
14%
Lactate Dehydrogenase
14%
Alpha Tocopherol
14%
Mouse Model
14%
Phosphatidylserine
14%
Flavonoid Antioxidants
14%
Bilirubin
14%
Membrane Lipid
14%
Thalassemia
14%
Thalassemia Intermedia
14%